Shunji Nakatake
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shunji Nakatake has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Shigeo Yoshida
J-CREST (Japan Clinical REtina STudy Group), Kagoshima 890-8544, Japan
2 shared publications - Hiroshi Enaida
Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka 812-8582, Japan
1 shared publication - Koh-Hei Sonoda
Department of Ophthalmology, Kyushu University, Fukuoka 812-8582, Japan
1 shared publication - Kohta Fujiwara
Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
1 shared publication - Miho Miyazaki
B Department of Ophthalmology, Graduate School of Medical Sciences , Kyushu University , Fukuoka , Japan
1 shared publication - Noriko Morioka
Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Maidashi, Higashi-ku, Fukuoka, Japan
1 shared publication
Latest Publications
- Open Access
- 22 September 2016
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 1 (15) , e87781
MUTYH promotes oxidative microglial activation and inherited retinal degeneration
Oxidative stress is implicated in various neurodegenerative disorders, including retinitis pigmentosa (RP), an inherited disease that causes blindness. The biological and cellular mechanisms by which oxidative stress mediates neuronal cell death are largely unknown. In a mouse model of RP (rd10 mice), we show that oxidative DNA damage activates microglia through MutY homolog–mediated (MUYTH-mediated) base excision repair (BER), thereby exacerbating retinal inflammation and degeneration. In the early stage of retinal degeneration, oxidative DNA damage accumulated in the microglia and caused single-strand breaks (SSBs) and poly(ADP-ribose) polymerase activation. In contrast, Mutyh deficiency in rd10 mice prevented SSB formation in microglia, which in turn suppressed microglial activation and photoreceptor cell death. Moreover, Mutyh -deficient primary microglial cells attenuated the polarization to the inflammatory and cytotoxic phenotype under oxidative stress. Thus, MUTYH-mediated BER in oxidative microglial activation may be a novel target to dampen the disease progression in RP and other neurodegenerative disorders that are associated with oxidative stress.
- 22 September 2016
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 1 (15) , e87781
Open AccessMUTYH promotes oxidative microglial activation and inherited retinal degeneration
Oxidative stress is implicated in various neurodegenerative disorders, including retinitis pigmentosa (RP), an inherited disease that causes blindness. The biological and cellular mechanisms by which oxidative stress mediates neuronal cell death are largely unknown. In a mouse model of RP (rd10 mice), we show that oxidative DNA damage activates microglia through MutY homolog–mediated (MUYTH-mediated) base excision repair (BER), thereby exacerbating retinal inflammation and degeneration. In the early stage of retinal degeneration, oxidative DNA damage accumulated in the microglia and caused single-strand breaks (SSBs) and poly(ADP-ribose) polymerase activation. In contrast, Mutyh deficiency in rd10 mice prevented SSB formation in microglia, which in turn suppressed microglial activation and photoreceptor cell death. Moreover, Mutyh -deficient primary microglial cells attenuated the polarization to the inflammatory and cytotoxic phenotype under oxidative stress. Thus, MUTYH-mediated BER in oxidative microglial activation may be a novel target to dampen the disease progression in RP and other neurodegenerative disorders that are associated with oxidative stress.
- Open Access
- 26 April 2014
- Published by Springer Nature in BMC Ophthalmology
- Vol. 14 (1) , 55
Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis
Several retinal ischemic diseases can cause neovascular glaucoma (NVG). Trabeculectomy with mitomycin C (MMC) is a relatively better treatment modality in the management of eyes with NVG than other glaucoma surgeries. The aim of this study was to investigate the factors that may influence the outcome of trabeculectomy with MMC for NVG.
- 26 April 2014
- Published by Springer Nature in BMC Ophthalmology
- Vol. 14 (1) , 55
Open AccessHyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis
Several retinal ischemic diseases can cause neovascular glaucoma (NVG). Trabeculectomy with mitomycin C (MMC) is a relatively better treatment modality in the management of eyes with NVG than other glaucoma surgeries. The aim of this study was to investigate the factors that may influence the outcome of trabeculectomy with MMC for NVG.